
Regulatory delays in P&C filings are predictable, compounding, and largely fixable. A new ZestyAI research analysis of where filings actually break down shows the problem isn't primarily oversight — it's execution. Breakdowns cluster around a small number of recurring failure points, almost all of them early in the process, and once an objection cycle starts, delay compounds disproportionately with each round. The result is months of slippage that quietly erodes pricing effectiveness and consumes scarce actuarial and regulatory capacity.
About this analysis. Findings are drawn from analysis of recent P&C rate, rule, and form filings using Zorro Discover, ZestyAI's AI agent purpose-built for insurance-specific research. The full report — Where P&C Filings Go Off Track — is an 8-page research analysis of filing breakdowns and the execution patterns that separate teams that manage delay from those that systematically reduce it.
Want the data? Download the full report →
Not where most teams assume. Filings don't typically stall during deep technical review by regulators — they stall earlier, during submission, packaging, and initial support. Procedural gaps and missing exhibits trigger objections before reviewers ever engage with the substantive content of the filing. That's the first counterintuitive finding: a meaningful share of delay is generated before the regulator has even started evaluating the rate change, model factor, or rule update being filed.
The implication is that delay is largely an upstream problem with upstream fixes.
Each objection round resets the review clock and expands the scope of scrutiny. What looks like a small clarification request adds weeks; a second cycle adds months; a third compounds further as the reviewer's questions broaden to adjacent assumptions. Once a filing is in the objection loop, timelines stretch disproportionately, not linearly. This is the second pattern: delay is non-linear, and most filing teams don't price the compounding cost of the second and third cycle into their internal timeline forecasts.
The carriers that move fastest are the ones that prevent the first objection — not the ones that respond to it well.
The cost of delay is measurable, even when it's not always measured. Late effective dates scale impact in two directions at once: across the premium book affected by the change, and across the time the carrier operates under the prior (often inadequate) rates. A rate change that earns full approval three months late doesn't just lose three months of expected premium — it continues exposing the carrier to the loss patterns that motivated the change in the first place. Meanwhile, actuarial and regulatory teams burn cycles managing the objection process rather than building the next filing.
They treat approval readiness as an operating capability, not a one-time deliverable. High-performing teams standardize how filings are packaged, build internal review against the procedural patterns regulators care about most, and use the institutional history of prior objections — their own and the market's — to anticipate the questions a reviewer will ask before the reviewer asks them. The performance gap between organizations isn't about regulatory environment or filing volume. It's about whether the filing function is built for speed.
As filings grow more complex and regulatory expectations rise, the gap is widening between organizations that manage delay and those that systematically reduce it. The pricing decisions, product changes, and risk responses being filed today only matter to the extent they reach the market when intended. Approval readiness is increasingly what separates carriers that translate strategy into results from those that watch their best work stall in the review queue.
Where P&C Filings Go Off Track →
The 8-page report walks through the specific breakdown patterns, where objection cycles start, how delay compounds across rounds, and how high-performing teams systematically reduce both.
Download the report — or request a trial of Zorro Discover to access the institutional filing history that lets teams anticipate regulator objections before they arrive.